The Centers for Medicare & Medicaid Services today approved for Oklahoma the first state Medicaid plan amendment to allow supplemental rebate agreements involving value-based purchasing arrangements with drug makers. The value-based agreements could produce extra rebates for the state if clinical outcomes are not achieved. “Oklahoma’s plan for value-based drug contracts is an important example of how states can innovate to bring down drug costs,” said Health and Human Services Secretary Alex Azar. In addition, CMS today approved an amendment to Massachusetts’ Section 1115(a) Medicaid demonstration, MassHealth, which permits the state to provide coverage to certain veterans and family members who receive income from state veteran annuities. Massachusetts also proposed a number of flexibilities which CMS did not approve but on which it continues to work with the state, including a request to exclude certain Medicaid-covered outpatient drugs through a closed formulary. In other news, CMS today sent a letter to states clarifying that drugs approved under section 506(c) of the Federal Food, Drug, and Cosmetic Act are covered outpatient drugs and must be covered by states consistent with the Medicaid Drug Rebate Program.

Related News Articles

Headline
The Centers for Medicare…
Headline
The House Energy and Commerce Subcommittee on Health today held a hearing on 12 health care bills, including one that would impact the Medicaid…
Headline
The Centers for Medicare…
Headline
President Trump last week released an executive order directing relevant agencies to update procedures, guidance or regulations to ensure that ineligible non-…
Headline
The Government Accountability Office yesterday named two new members to the Medicaid and CHIP Payment and Access Commission.
Headline
Despite some progress in transparency related to the process for Section 1115 Medicaid waivers, the Centers for Medicare…